The following research will debut at the ISTH 2026 Congress through simultaneous publication.

 

For questions or more information, contact Barbara Krolak, ISTH Marketing Manager, at Barbara_Krolak@isth.org.

​​

“Rivaroxaban Then Aspirin vs. Aspirin Alone After Total Hip or Knee Arthroplasty”

• Journal: The New England Journal of Medicine (NEJM)

• Publication Date: Sunday, July 12, 2026, 11:15 a.m. CEST (*Note: Under embargo until ISTH 2026 late-breakthrough session)

• Authors: Sudeep Shivakumar, MD1,2, Davide Matino, MD3, David Zukor, MD4, Susan R. Kahn, MD5, George Vincent, MD6,7, Raman Mundi, MD7,8, Pascal-Andre Vendittoli, MD9,10, Mohammad Refaei MD3,11, Eric Bohm, MD12,13, Michael Tanzer, MD4, Stéphane Pelet, MD10,14, Glen Richardson, MD15, James Powell, MD16, Rick Ikesaka, MD17, James Douketis, MD3, Sarah Ward, MD7, Paul Kim, MD18, Stephen Mann, MD19, Susan Pleasance, BScN2, Jocelyn Cormier, BSc2, Pantelis Andreou, PhD20, Kara Matheson, MSc2, Chris Theriault, BEng2, Carol West, MA21, David Anderson, MD1 and Peter L. Gross, MD22 , for The EPCAT III Study collaborators.

 

“Incidence of Occult Cancer Detection and Effectiveness of Screening Strategies After Unprovoked Venous Thromboembolism in Thailand”

• Journal: Blood Global Hematology

• Publication Date: July 12, 2026

• Authors: Salisa Sakulrojanawong, Tanapun Thamgrang, Kannadit Prayongratana, Chonlada Laoruangroj, Panachai Silpsamrit, Pornpavee Siricharoenthai, Rattapan Lamool

• Link: https://doi.org/10.1016/j.bglo.2026.100070 (will publish on July 12, 2026)  

 

“Correlation between dilute Russell's viper venom time (dRVVT) and apixaban concentrations: Potential utility and limitations in emergency settings”

• Journal: Thrombosis Research

• Presenting Author: Dr. Tanapun Thamgrang (Thailand)

• Link (published May 2026): https://www.thrombosisresearch.com/article/S0049-3848(26)00099-X/abstract

• Note: Presented as a poster presentation on July 13, 2026, from 13:45–14:45

​

"A rapid ADAMTS13 activity assay using a portable readout device"

• Journal: Blood VTH (vessels, thrombosis & hemostasis)

• Author name: Theodora J. Steeghs (The Netherlands)

• Link: https://doi.org/10.1016/j.bvth.2026.100179
   

“Mesoglycan for Long-Term Secondary Prevention in Patients with Superficial Vein Thrombosis (METRO Study): A Multicentre Randomised Clinical Trial in Italy”

• Journal: eClinicalMedicine

• Publication Date: July 11, 2026, 11:30 p.m.

• Lead Author: Giuseppe Camporese (Italy)

 

“Antiplatelet activity of novel aminoestrogens: R-β-mefenetame as a candidate for safer estrogen-based therapies”

• Journal: The Journal of Steroid Biochemistry and Molecular Biology

• Lead Author: Aurora De La Peña (Mexico)

• Link: www.sciencedirect.com/science/article/pii/S0960076026001093?via%3Dihub

 

“Subjective theory of illness, disease perception, and attitude toward anticoagulation therapy in patients with unprovoked venous thromboembolism—the qualitative Dalí study”

• Journal: Journal of Thrombosis and Haemostasis (JTH)

• Lead Author: Daniel Steiner (Austria)

• Link (published June 2026): www.jthjournal.org/article/S1538-7836(26)00354-5/fulltext

• Note: The research will be shared as part of the oral communications session, "Contemporary issues in anticoagulation,” on Sunday, 12 July, 14:45 - 16:00 CEST.

 

“Recurrent venous thromboembolism during extended apixaban therapy for cancer-associated thrombosis: clinical presentation and short-term outcomes. Insights from the API-CAT proepective randomized double-blind trial”

• Journal: Circulation (American Heart Association)

• Author: Dr. Isabelle Mahe

• Presentation number: OC 41.1

​

​